University of Vermont

College of Nursing and Health Sciences

Department of Communication Sciences and Disorders

Providing Quality Services on a Shoestring

Autism Spectrum Disorders: On the Frontiers of Research, Clinical Practice, Professional Training and Community Viability

Jennifer L. Stapel-Wax, PsyD

Associate Professor
Division of Autism and Related Disorders
Department of Pediatrics
Emory University School of Medicine

Director of Infant and Toddler Clinical Research Operations
Marcus Autism Center
Children's Healthcare of Atlanta

Jennifer L. Stapel-Wax

Dr. Stapel-Wax is the Director of Infant and Toddler Clinical Research Operations at the Marcus Autism Center at Children's Healthcare of Atlanta. She completed her doctorate in clinical psychology at the Georgia School of Professional Psychology, an internship in pediatric behavioral medicine and neurodevelopmental disabilities at Miami Children’s Hospital and a postdoctoral fellowship in neuropsychology and neurodevelopmental disabilities at the Marcus Center/Emory University postdoctoral fellowship program. Dr. Stapel-Wax has over 15 years of experience clinically assessing children with neurodevelopmental disorders. She is an accomplished speaker and teacher as well as an expert in building strong collaborative relationships focused on training, education, and service delivery. Her current focus is to both participate in research on infants and toddlers at risk for ASD centered at the Marcus Autism Center and direct efforts and projects for infants and toddlers in the community and in public policy. She is currently leading several community outreach efforts to build a community viable healthcare system for infants and toddlers. Dr. Stapel-Wax is a Past-President and long time board member of the Georgia Psychological Association. 

Presentation overview
This presentation describes research at the Marcus Autism Center focusing on early screening and detection. It explains the impact of ASD on development, scientific tools for screening in the community, risk and resilience factors impacting prognosis, and interventions targeting ASD characteristics.

Educational objectives
As a result of this session, participants will be able to:

  1. List factors contributing to autism etiology and the social neuroscience of early childhood development
  2. Describe new technologies and science in early screening and detection
  3. Explain assessment of ASD in very young children and promising early intervention methods
  4. Identify intervention models that are community viable and sustainable
  5. Describe community and public policy implications of current science and clinical practice

Time-ordered agenda

8:30-10:00 Understanding the etiology of autism and the social neuroscience impacting early development
10:00-10:15 BREAK
10:15-12:00 Developing reliable screening tools in community settings
12:00-1:15 LUNCH
1:15-3:00 Utilizing community viable and sustainable intervention models and exploring community and public policy implications for science and practice

Dr. Stapel-Wax is employed by Emory University School of Medicine. Disclosures: Financial: Honoraria from the University of Vermont for travel and speaking at this conference; speaking fee for teaching from the Tennessee Council for Exceptional Children; speaking fee for teaching from Eastern Virginia Medical School; speaking fee for teaching at Georgia Psychological Association. Non-financial: past president of Georgia Psychological Association; Principal Investigator on grant from United Way of Greater Atlanta.

Last modified March 31 2014 12:53 PM